Charli XCX 'Apple' dance creator Kelley Heyer sues gaming platform Roblox for copyright violation after the dance was used in 'Dress to Impress.' ...

As Blue Dream does the rounds on TikTok and Instagram Reels, we take a look back at the song’s release, Dance Gavin Dance’s ever-changing line-up, Jonny’s career, and what exactly the Macbook scandal ...

Additionally, Chief Minister Pinarayi Vijayan has stated that he will explore the possibility of introducing Zumba dance in public ... to discuss the state's anti-drug action plan.

The Food and Drug Administration’s chief vaccine regulator has been pushed out of the agency, in what could be a troubling sign of Health Secretary Robert F. Kennedy Jr.’s efforts to advance ...

A top vaccine official at the Food and Drug Administration (FDA) resigned, citing Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s “misinformation” and apparent lack of ...

Dr. Peter Marks, a veteran official at the Food and Drug Administration (FDA) who helped establish the U.S. effort to rapidly develop Covid-19 vaccines, resigned on Friday. “It has become clear ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...

Health and Human Services Secretary Robert F. Kennedy Jr. and his allies rallied around removing industry influence from the Food and Drug Administration as part of their quest to Make America ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.

A license plate obscured by an Eagles logo led to the arrest of two people ... possession of a controlled substance, use of drug paraphernalia and use of marijuana. McNiss was also charged with ...

FDA Issues Nyxoah an Approvable Letter for its Genio® System Mont-Saint-Guibert, Belgium – March 26, 2025, 8:00am CET / 3:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine ...